Novo Nordisk to explore how GLP-1 drugs can help patients with addiction
ReutersMar 6, 2025 9:15 AM
COPENHAGEN, March 6 (Reuters) - Novo Nordisk NOVOb.CO will explore how GLP-1 drugs potentially could help patients struggling with addiction, its head of development Martin Holst Lange told an online press conference on Thursday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What Is Worldcoin? Why Did WLD Surge Suddenly, and What’s Next?
Worldcoin is evolving from a “hype token” into a foundational layer for global identity. Its fusion of biometrics, blockchain, and financial inclusion has earned growing recognition from users and institutions. If it can overcome technical hurdles, launch real-world payment use cases, and stabilizeTradingKey
3 hours ago
Why Does Hyperliquid Keep Hitting New Highs? Can HYPE Continue Its Rally?
Hyperliquid is a decentralized derivatives trading platform launched in 2023, designed to deliver high-performance, low-latency, permissionless trading. Its mission is to offer a self-custodied and transparent experience that rivals, or even surpasses, centralized exchanges (CEXs) — earning it the nTradingKey
4 hours ago
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.TradingKey
Mon, Sep 8
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
Tradingkey
